Ethical issues in colorectal cancer screening

Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jun...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Baillière's best practice & research. Clinical gastroenterology 2014-04, Vol.28 (2), p.315-326
Hauptverfasser: van Dam, Leonie, MD, PhD, Bretthauer, Michael, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 326
container_issue 2
container_start_page 315
container_title Baillière's best practice & research. Clinical gastroenterology
container_volume 28
creator van Dam, Leonie, MD, PhD
Bretthauer, Michael, MD, PhD
description Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review.
doi_str_mv 10.1016/j.bpg.2014.03.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1535631776</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1521691814000262</els_id><sourcerecordid>3294637491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</originalsourceid><addsrcrecordid>eNp9kc1LAzEQxYMotlb_AC9S8OJl18wkm-0iCCJ-geBBPYdsMtXU7W5NWsH_3iz1A3rwlCG895j3G8YOgefAQZ3O8nrxkiMHmXORc45bbAiFwAwqUNv9jJCpCiYDthfjjPNkqqpdNkA5SQEVDll2tXz11jRjH-OK4ti3Y9s1XSC7TJ_WtJbCONpA1Pr2ZZ_tTE0T6eD7HbHn66uny9vs_uHm7vLiPrNK4jIzQipeSCNNbWpXKScIJo5UWWNNKBw4YaG2hSyNwxKraVFMytJUIEFgLadixE7WuYvQvae1lnruo6WmMS11q6hTyUIJKEuVpMcb0lm3Cm3aTvf1ueAImFSwVtnQxRhoqhfBz0341MB1z1LPdGKpe5aaC51YJs_Rd_KqnpP7dfzAS4KztYASig9PQUfrKRFzvuenXef_jT_fcNvGt_0t3uiT4l8LHVFz_di36W8JMt0RFYovz32Wlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1521030212</pqid></control><display><type>article</type><title>Ethical issues in colorectal cancer screening</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>van Dam, Leonie, MD, PhD ; Bretthauer, Michael, MD, PhD</creator><creatorcontrib>van Dam, Leonie, MD, PhD ; Bretthauer, Michael, MD, PhD</creatorcontrib><description>Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review.</description><identifier>ISSN: 1521-6918</identifier><identifier>EISSN: 1532-1916</identifier><identifier>DOI: 10.1016/j.bpg.2014.03.002</identifier><identifier>PMID: 24810192</identifier><identifier>CODEN: BPRCB6</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Clinical trials ; Colonography, Computed Tomographic ; Colorectal cancer ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - prevention &amp; control ; CT-colonography ; Early Detection of Cancer - ethics ; Endoscopy ; Endoscopy, Gastrointestinal ; Ethics ; Faecal occult blood test ; Gastroenterology and Hepatology ; Hospitals ; Humans ; Mass Screening - ethics ; Medical screening ; Mortality ; Occult Blood ; Occult sciences ; screening</subject><ispartof>Baillière's best practice &amp; research. Clinical gastroenterology, 2014-04, Vol.28 (2), p.315-326</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Apr 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</citedby><cites>FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1521691814000262$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24810192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Dam, Leonie, MD, PhD</creatorcontrib><creatorcontrib>Bretthauer, Michael, MD, PhD</creatorcontrib><title>Ethical issues in colorectal cancer screening</title><title>Baillière's best practice &amp; research. Clinical gastroenterology</title><addtitle>Best Pract Res Clin Gastroenterol</addtitle><description>Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review.</description><subject>Clinical trials</subject><subject>Colonography, Computed Tomographic</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - prevention &amp; control</subject><subject>CT-colonography</subject><subject>Early Detection of Cancer - ethics</subject><subject>Endoscopy</subject><subject>Endoscopy, Gastrointestinal</subject><subject>Ethics</subject><subject>Faecal occult blood test</subject><subject>Gastroenterology and Hepatology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Mass Screening - ethics</subject><subject>Medical screening</subject><subject>Mortality</subject><subject>Occult Blood</subject><subject>Occult sciences</subject><subject>screening</subject><issn>1521-6918</issn><issn>1532-1916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1LAzEQxYMotlb_AC9S8OJl18wkm-0iCCJ-geBBPYdsMtXU7W5NWsH_3iz1A3rwlCG895j3G8YOgefAQZ3O8nrxkiMHmXORc45bbAiFwAwqUNv9jJCpCiYDthfjjPNkqqpdNkA5SQEVDll2tXz11jRjH-OK4ti3Y9s1XSC7TJ_WtJbCONpA1Pr2ZZ_tTE0T6eD7HbHn66uny9vs_uHm7vLiPrNK4jIzQipeSCNNbWpXKScIJo5UWWNNKBw4YaG2hSyNwxKraVFMytJUIEFgLadixE7WuYvQvae1lnruo6WmMS11q6hTyUIJKEuVpMcb0lm3Cm3aTvf1ueAImFSwVtnQxRhoqhfBz0341MB1z1LPdGKpe5aaC51YJs_Rd_KqnpP7dfzAS4KztYASig9PQUfrKRFzvuenXef_jT_fcNvGt_0t3uiT4l8LHVFz_di36W8JMt0RFYovz32Wlw</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>van Dam, Leonie, MD, PhD</creator><creator>Bretthauer, Michael, MD, PhD</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20140401</creationdate><title>Ethical issues in colorectal cancer screening</title><author>van Dam, Leonie, MD, PhD ; Bretthauer, Michael, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c642t-a346054a4ababd96d3e18de67b2be23d1d3c1bc547ad2729f55877a914132b4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Clinical trials</topic><topic>Colonography, Computed Tomographic</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - prevention &amp; control</topic><topic>CT-colonography</topic><topic>Early Detection of Cancer - ethics</topic><topic>Endoscopy</topic><topic>Endoscopy, Gastrointestinal</topic><topic>Ethics</topic><topic>Faecal occult blood test</topic><topic>Gastroenterology and Hepatology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Mass Screening - ethics</topic><topic>Medical screening</topic><topic>Mortality</topic><topic>Occult Blood</topic><topic>Occult sciences</topic><topic>screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Dam, Leonie, MD, PhD</creatorcontrib><creatorcontrib>Bretthauer, Michael, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Baillière's best practice &amp; research. Clinical gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Dam, Leonie, MD, PhD</au><au>Bretthauer, Michael, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ethical issues in colorectal cancer screening</atitle><jtitle>Baillière's best practice &amp; research. Clinical gastroenterology</jtitle><addtitle>Best Pract Res Clin Gastroenterol</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>28</volume><issue>2</issue><spage>315</spage><epage>326</epage><pages>315-326</pages><issn>1521-6918</issn><eissn>1532-1916</eissn><coden>BPRCB6</coden><abstract>Abstract In many countries, colorectal cancer screening is currently an established population screening program due to the evidence on its reduction of colorectal cancer mortality. There is general consensus that colorectal cancer screening meets the screening criteria as proposed by Wilson and Jungner. However, as for all population screening programs, colorectal cancer screening also has disadvantages and thereby entails ethical issues. There are the general issues concerning the introduction of screening programs (e.g. medicalization, overdiagnosis and overtreatment, information provision to screenees), evaluation of cancer screening programs (e.g. lead time and length bias), chosen screening method (e.g. false-positive and false-negative test results, reduction of all-cause mortality, choice between different screening methods). The different colorectal cancer screening methods and the ethical issues concerning colorectal cancer screening will be discussed in this review.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>24810192</pmid><doi>10.1016/j.bpg.2014.03.002</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1521-6918
ispartof Baillière's best practice & research. Clinical gastroenterology, 2014-04, Vol.28 (2), p.315-326
issn 1521-6918
1532-1916
language eng
recordid cdi_proquest_miscellaneous_1535631776
source MEDLINE; Elsevier ScienceDirect Journals
subjects Clinical trials
Colonography, Computed Tomographic
Colorectal cancer
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - prevention & control
CT-colonography
Early Detection of Cancer - ethics
Endoscopy
Endoscopy, Gastrointestinal
Ethics
Faecal occult blood test
Gastroenterology and Hepatology
Hospitals
Humans
Mass Screening - ethics
Medical screening
Mortality
Occult Blood
Occult sciences
screening
title Ethical issues in colorectal cancer screening
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A41%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ethical%20issues%20in%20colorectal%20cancer%20screening&rft.jtitle=Bailli%C3%A8re's%20best%20practice%20&%20research.%20Clinical%20gastroenterology&rft.au=van%20Dam,%20Leonie,%20MD,%20PhD&rft.date=2014-04-01&rft.volume=28&rft.issue=2&rft.spage=315&rft.epage=326&rft.pages=315-326&rft.issn=1521-6918&rft.eissn=1532-1916&rft.coden=BPRCB6&rft_id=info:doi/10.1016/j.bpg.2014.03.002&rft_dat=%3Cproquest_cross%3E3294637491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1521030212&rft_id=info:pmid/24810192&rft_els_id=S1521691814000262&rfr_iscdi=true